https://ift.tt/Aqzhbya from Sanofi - Aventis Groupe https://ift.tt/PQMzayZ via IFTTT " May good health envelop you, spurring a quic...
Press Release: Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline
https://ift.tt/Kl9DIjw from Sanofi - Aventis Groupe https://ift.tt/ZbBke74 via IFTTT " May good health envelop you, spurring a q...
Media Update: Dupixent® (dupilumab) U.S. label updated with data further supporting use in atopic dermatitis with moderate-to-severe hand and foot involvement
https://ift.tt/s0lOVQM from Sanofi - Aventis Groupe https://ift.tt/CLPUQ4n via IFTTT " May good health envelop you, spurring a quic...
Press Release: Brian Foard appointed Head of Specialty Care Global Business Unit, member of Sanofi Executive Committee
https://ift.tt/jkugvqX from Sanofi - Aventis Groupe https://ift.tt/W3z9Rxg via IFTTT " May good health envelop you, spurring a q...
Subscribe to:
Posts
(
Atom
)